Drug factory · FDA FEI 3007164063
Viyash Scientific Limited
UNIT-III, Survey No. 353, 354 & 467, Domadugu (Village), Gummadidala (Mandal), Sangareddy, India
Problems found, fixed voluntarily at FDA's last inspection, Dec 6, 2024.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
4 drug inspections on record since 2015: 0 with no problems, 4 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Linezolid | Makes the active ingredient | Pharmacia & Upjohn Company LLC | 0009-4992 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Dec 6, 2024 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Jul 28, 2018 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| May 4, 2018 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Jun 5, 2015 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: api manufacture.